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AnticancerAbstract A series of cobalt, nickel and copper complexes of bidentate Schiff base derived from the
condensation reaction of 4-amino-5-mercapto-3-methyl-1,2,4-triazole with 2-nitrobenzaldehyde
had been synthesized. The synthesized Schiff base and their metal complexes have been character-
ized with the support of more than a few physicochemical techniques, elemental evaluation, mag-
netic moment measurements, spectroscopic, thermo gravimetric techniques and X-ray powder
diffraction. Spectral analysis exhibits square planer geometry for Cu(II) complex while octahedral
geometry for Co(II) and Ni(II) complexes. The Schiff base and their complexes have been screened
for their anticancer activity using MCF7 cell line. In molecular docking learn exhibits that Ni(II)
complex is more active conﬁrmed quantity of interaction in particular hydrogen bond interaction
with ASN142 and charge interactions with ASP97 and GLU99.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cisplatin discovery in 1965 proved a milestone in the drug discovery of
metal based anticancer agents. In recent years the metalo-
pharmaceuticals attracted attention of the scientiﬁc fraternity.Currently various metalo-pharmaceuticals such as bismuth subsalicy-
late (anti-diarrheal), auranoﬁn (anti-inﬂammatory for treatment of
arthritis), silver sulfadiazine (antibacterial) and zinc pyrithione
(antibacterial and antifungal) are in the clinical use. Breast cancer is
leading cause of death in women in recent years. Breast cancer is
accounting for total 23% of all cancer cases in women, and the death
percentage of the patient suffering from this cancer rises to 16% of all
cancer deaths. The emergence of the some new types such as triple neg-
ative breast cancer, development of new and potent therapeutic agents
targeting novel target against breast cancer is need of time. CDK or
Cyclin-dependent kinases are the family of the heterodimer kinases
which are having critical role in the regulation of cell cycle progression
and transcription. Deregulation of these kinases leads to proliferation
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found in variety of the cancers. So inhibition of these kinases will be
acting as attractive target for development of new anticancer agents.
The chemistry of Schiff bases and their structural analogues have
occupied a position of considerable signiﬁcance (Gornovskii et al.,
2009) as they form steady complexes with most transition metal ions
(Heshmatpour et al., 2007; Nuria et al., 2005) and exhibit well-
established biological properties (Manikshete et al., 2011). 1,2,4-
triazole nucleus and their derivatives emerge quickly with the advances
of modern heterocyclic chemistry, promising a variety of scientiﬁc
purposes comparable to antibacterial, antifungal, anticancer, antitu-
mor, anticonvulsant, anti-inﬂammatory, and analgesic properties
(Turan-Zitouni et al., 2005; Walczak et al., 2004; Mavrova et al.,
2009; Al-Soud et al., 2003; Almasirad et al., 2004; Amir and Shikha,
2004).
Schiff bases of 1,2,4-triazoles ﬁnd diverse applications and huge
biological activity. The incorporation of the 1,2,4-triazole unit into
Schiff base macro cycles is of colossal current curiosity as complexes
of 1,2,4-triazoles are being developed for knowledge use in purposes
akin to magnetic substances and image chemically pushed molecular
instruments (Brandt et al., 2007). Schiff bases derived from
3-substituted 4-amino-5-mercapto-1,2,4-triazoles show analgesic,
antimicrobial, anti-inﬂammatory and antidepressant activities
(Bekircan and Bektas, 2006). These motives caused us to carry out gain
knowledge of synthesis of Schiff base and its complexes with Co(II),
Ni(II) and Cu(II) metal ions.Scheme
Table 1 Analytical and physical data of the Schiff base (HL) and C
Comp. Molecular formula Mol. Wt. Color
HL C10H9N5SO2 263 Pale yellow
HL-Co C20H20N10S2O6Co [Co(L)22H2O] 618.93 Olive gree
HL-Ni C20H20N10S2O6Ni [Ni(L)22H2O] 618.91 Green
HL-Cu C20H16N10S2O4Cu [Cu(L)2] 587.54 Brick redThe intention of present communication is to gain knowledge of
bioactivities of 1,2,4-triazole Schiff base and reap the relative deriva-
tives with better curing effect and strengthen bioavailability with the
aid of coordinating them with transition metal ions. The synthesized
Schiff base and their metal complexes have been characterized with
the aid of elemental analysis, magnetic moment measurements, spec-
troscopic, thermo gravimetric and X-ray powder diffraction
approaches. The Current manuscript deals with development of tran-
sition metal complexes of 1,2,4-triazoles and their anticancer screening
on the MCF 7 cell line. Thus, our study will give new useful insights for
designing metallo-pharmaceuticals for anticancer therapy.
2. Experimental
All reagents used, hydrazine hydrate, carbon disulﬁde, 2-
nitrobenzaldehyde, cobalt chloride, nickel chloride and copper
chloride were of AR grade. The solvents used were ethanol,
ethyl acetate, petroleum ether, dimethyl formamide (DMF)
and dimethyl sulfoxide (DMSO). The synthesis of Schiff base
ligand and metal complexes is proven in Scheme 1.
4-Amino-5-mercapto-3-methyl-1,2,4-triazole (AMMT) was
prepared by reported literature Method (Bala et al., 1978).
The AMMT (1.30 g, 0.01 M) and 2-nitrobenzaldehyde
(1.511 g, 0.01 M) were dissolved in ethanol (25 ml) individually1
o(II), Ni(II) and Cu(II) complexes.
Elemental analysis
C% found
(calc.)
H% found
(calc.)
N% found
(calc.)
M% found
(calc.)
45.20 (45.63) 3.52 (3.42) 26.48 (26.61) –
n 38.84 (38.78) 3.16 (3.23) 22.71 (22.62) 9.42 (9.52)
38.71 (38.78) 3.30 (3.23) 22.58 (22.62) 9.59 (9.52)
40.93 (40.85) 2.81 (2.72) 23.89 (23.83) 10.93 (10.81)
Table 2 Electronic spectral and magnetic measurement data.
Compd. c1 cm
1 c2 cm
1 c3 cm
1 Dq cm1 B cm1 c2/c1 cm
1 b cm1 b % leﬀ. BM
HL-Co 10,810 22,703* 21,276 1189.3 770 2.10 0.792 20.70 4.89
HL-Ni 9891 16,129 24,992 989.1 788.16 1.63 0.757 24.29 3.45
HL-Cu 17,993 – – 1799.3 – – – – 1.92
* Calculated value.
Table 3 IR spectral data of Schiff base [HL] and Co(II), Ni(II) and Cu(II) complexes.
Sr. no. Compound mC‚N cm
1 mSH cm
1 mC‚S cm
1 m(CA-S) cm
1 mH2O cm
1 mMAS cm
1 mMAN cm
1
1 HL 1590 2760 1114 – – – –
2 HL-Co 1525 – – 718 3395 355 515
3 HL-Ni 1525 – – 785 3206 379 483
4 HL-Cu 1567 – – 750 – 350 493
Figure 1 IR spectra of Schiff base (HL).
264 S.A. Deodware et al.in 1:1 molar ratio. The ethanolic solutions were mixed
together. The mixture was reﬂuxed on water bath for 3 h.
On cooling, a crystalline Schiff base, 4-(20-nitrobenzylidenei
mino)-3-methyl-5-mercapto-1,2,4-triazole (HL), used to be
separated via ﬁltration and crystals were washed with cold
ethanol and recrystallized from ethanol and dried in vacuum
over anhydrous CaCl2. The melting point of synthesized com-
pound was found to be 224 C.
The Schiff base (2.63 g, 0.01 M) was dissolved in 25 ml
ethanol and added to metal salt cobalt chloride (1.189 g,
0.005 M), Nickel chloride (1.188 g, 0.005 M) and copper chlo-
ride (0.852 g, 0.005 M)]. The mixture was reﬂuxed for 4 h. The
products formed were ﬁltered and puriﬁed by washing thor-
oughly with absolute ethanol and ﬁnally with acetone and
dried in vacuum over anhydrous CaCl2.
The sulphorhodamine B (SRB) evaluates were used for cell
density determination, based on the measurement of cellular
protein content. The process described right here was once
optimized for the toxicity screening of compounds to adherent
cells in a 96 well format. After an incubation period, cell
monolayers were ﬁxed with 10% (w/v) trichloroacetic acid
and stained for 30 min, after which the surplus dye was onceremoved with the aid of washing repeatedly with 1% (v/v)
acetic acid. The protein-bound dye is dissolved in 10 mM tris
base solution for OD resolution at 510 nm utilizing a micro
plate reader. The results had been linear over a 20-fold variety
of cell numbers and the sensitivity was comparable to those of
ﬂuorometric approaches.2.1. Molecular docking
To ascertain the mode of action of the synthesized metal
complexes molecular docking calculations are carried out
using a biopredicta module of the V life MDS 4.3. Virtual
analysis was carried out using the crystal structure of the
Human CDK 7 (PDB ID: IUA2) downloaded from Protein
Data Bank (www.rcsb.org/pdb) at a resolution of 3.02 A˚.
Protein structure was reﬁned via deletion of all the heteroa-
toms including water molecules and addition of the polar
hydrogen atoms to get a native conformation. All other
bonds were allowed to be rotatable. Structures of the synthe-
sized metal complexes are drawn in the builder module of the
V life MDS 4.3 engine. The 2D structures of the molecules
Figure 2 (a–c): IR spectra of Co(II), Ni(II) and Cu(II) complexes.
High acting anti breast cancer agents 265were converted into the 3D structures are optimized via
application of the MMFF force ﬁeld. These optimized struc-
tures were further utilized for the docking analysis. All calcu-
lations were performed on an Intel i3, based machine running
windows 7 as operating system. The docked protein ligandcomplex was further analyzed via docking score of the each
of the complex, which is nothing but the binding energy of
the complex, for every derivative best 100 binding conforma-
tion was analyzed to select the best conformation having the
minimum energy of the binding.
Figure 3 1H NMR spectra of Schiff base(HL).
Table 4 Thermal analysis Co(II), Ni(II) and Cu(II) complexes.
Compound. Step Temp. (C) TG mass% No. of moles Assignment
Calc. Found
[Co(L)22H2O] 1 50–175 5.81 6.74 2 AH4O2(water molecules)
2 175–425 48.14 46.37 2 AC14H10N4O4(organic moiety)
3 425–540 36.51 34.34 2 AC6H6N6S2(triazole ring)
12.10 12.57 ACoO(residue)
[Ni(L)22H2O] 1 50–180 5.81 6.92 2 AH4O2(water molecules)
2 180–400 48.14 46.11 2 AC14H10N4O4(organic moiety)
3 400–550 36.51 34.09 2 AC6H6N6S2(triazole ring)
12.10 12.94 ANiO(residue)
[Cu(L)2] 1 50–425 45.95 44.46 2 AC14H10N4O4(organic moiety)
2 425–750 43.22 42.84 2 AC6H6N6S2(triazole ring)
12.10 12.69 ACuO(residue)
Figure 4 TGA-DTA curve of Co(II) complex.
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Figure 5 Mass spectrum of Schiff base (HL).
Position [°2Theta]
20 30 40 50 60 70
Counts
0
10000
40000  2NBA
Search Unit Cell Result 1
(a)
Position [°2Theta]
20 30 40 50 60 70
Counts
0
2500
10000
 CU 2NBA
Search Unit Cell Result 1
(b)
Figure 6 XRD pattern of (a) ligand and (b) Cu(II) complexes.
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3.1. Elemental and physical data
The Schiff base used to be soluble in ethanol, methanol,
acetone, DMF and DMSO. The entire metal complexes arecolored, non-hygroscopic solid which might be steady in air,
insoluble in water and organic solvents but soluble in DMSO
and decomposed at higher temperature. The purity of ligands
and their metal complexes has been checked with the aid of
TLC. Based on elemental and spectral studies the geometry
of synthesized compounds has been elucidated. By the
Table 5 Crystallographic data of ligand (HL).
Pos. [2Th.] Height [cts] FWHM [2Th.] d-spacing [A˚] Rel. Int. [%]
21.7677 6477.85 0.2922 4.08292 16.87
23.4049 1732.92 0.2922 3.80089 4.51
24.4578 5927.24 0.1948 3.63961 15.44
25.2393 1805.91 0.1948 3.52865 4.70
25.7877 3311.21 0.2922 3.45484 8.62
26.6576 38391.45 0.2922 3.34404 100.00
27.5059 3839.91 0.1948 3.24280 10.00
29.1995 2666.54 0.4871 3.05847 6.95
30.8622 3803.80 0.2922 2.89737 9.91
31.6022 186.68 0.2922 2.83120 0.49
32.5568 302.31 0.3897 2.75034 0.79
33.7386 576.15 0.2922 2.65665 1.50
36.4505 341.38 0.2922 2.46498 0.89
38.8494 258.24 0.2922 2.31812 0.67
40.0260 335.37 0.4871 2.25265 0.87
42.3468 700.98 0.2922 2.13441 1.83
43.4795 733.64 0.2922 2.08140 1.91
44.3787 282.75 0.2922 2.04129 0.74
45.5015 1526.86 0.2922 1.99350 3.98
47.2986 207.64 0.2922 1.92186 0.54
49.4470 535.30 0.2922 1.84328 1.39
50.2646 286.13 0.2922 1.81520 0.75
52.0517 385.04 0.4871 1.75700 1.00
55.1115 524.00 0.2922 1.66648 1.36
56.6904 200.42 0.4871 1.62376 0.52
58.1296 234.93 0.4752 1.58564 0.61
Table 6 Crystallographic data of Cu(II) complex.
Pos. [2Th.] Height [cts] FWHM [2Th.] d-spacing [A˚] Rel. Int. [%]
21.8271 3375.11 0.2922 4.07195 26.67
23.8238 577.05 0.2922 3.73499 4.56
25.6116 2163.59 0.2922 3.47820 17.09
28.3234 12657.35 0.2922 3.15104 100.00
29.5388 3022.92 0.2922 3.02410 23.88
30.4227 3626.43 0.2922 2.93823 28.65
31.6520 1500.20 0.2922 2.82686 11.85
34.6912 762.07 0.2922 2.58585 6.02
36.2253 1666.66 0.2922 2.47979 13.17
39.1207 1117.85 0.2922 2.30266 8.83
40.7282 1366.82 0.3897 2.21542 10.80
41.5311 1083.03 0.2922 2.17443 8.56
43.4820 876.44 0.4871 2.08128 6.92
44.5875 551.90 0.2922 2.03222 4.36
47.7587 940.21 0.2922 1.90442 7.43
50.6635 654.54 0.2922 1.80184 5.17
51.8466 532.77 0.3897 1.76347 4.21
55.5373 465.59 0.3897 1.65471 3.68
60.3664 362.06 0.4752 1.53212 2.86
268 S.A. Deodware et al.elemental analysis, the stoichiometry of ligand and their metal
complexes is conﬁrmed. The elemental analyses of ligand and
metal complexes are found in agreement with the proposed
structure of ligand and the metal complexes. Analytical and
physical data of the Schiff base(HL) and Co(II), Ni(II) and
Cu(II) complexes are listed in Table 1.3.2. Electronic spectral analysis and magnetic studies
The electronic spectra and magnetic moments of the com-
pounds are very useful in the evaluation of results acquired
by using different ways of structural investigation. The infor-
mation regarding the geometry of the complexes around the
Table 7 Unit cell parameters, volume and space group of ligand and Cu(II) complexes.
Compound Lattice constants (A˚) Volume, (A˚)3 Space group Crystallite size, (A˚)
HL a= 16.61, b= 8.16, c= 3.91 529.96 I m a m 337
HL-Cu a= 4.90, b= 4.90, c= 21.1, 506.90 I 41/a c d 182
High acting anti breast cancer agents 269Co(II), Ni(II) and Cu(II) ion was obtained from electronic
spectral studies and magnetic moments. The electronic spectra
of ligand and their metal complexes were recorded at room
temperature utilizing DMSO as a solvent.
The electronic spectra of ligand exhibit band at
29,585 cm1 which will also be assigned to n? p* transition
of azomethine group. Within the spectra of complexes, the
bands of azomethine chromophore because of n? p* transi-
tion are shifted to lower frequencies indicate that imine nitro-
gen is concerned in the coordination of metal ion.
Co(II) complex exhibits two absorption bands at
10,810 cm1 (c1) and 21,276 cm
1 (c3) which might be assigned
to 4T1g(F)?
4T2g (F) (c1);
4T1g(F)?
4T1g (P) (c3) transitions
(Avji et al., 2008; Kulkarni et al., 2011). These are attribute
bands of high spin octahedral Co(II) complexes; c2 is not
observed, but it may be calculated by using relation
c2 = c1 + 10Dq, which may be very nearly (c3) transition.
These transitions propose a octahedral environment around
Co(II) ion which was once extra supported by using its mag-
netic moment value of (leff) 4.89BM.
Ni(II) complex generally shows three absorption bands in
octahedral environment corresponding to 3A2g (F)?
3T2g
(F) (c1),
3A2g (F)?
3T1g (F) (c2), and
3A2g (F)?
3T1g (P)
(c3) transitions (Cotton et al., 2003). Ni (II) complex exhibits
above three transitions at 9891 cm1 (c1), 16,129 cm
1 (c2),
and 24,992 cm1 (c3) suggesting octahedral geometry whichTable 8 GI50 values of ligand and metal complexes.
Sr. no. Molecular code GI50
1 HL 64.1
2 HL-Co 35.7
3 HL-Ni 59.9
4 HL-Cu 54.9
Figure 7 Growth curve: human breast cancer cell line MCF-7.is further proven through its magnetic moment value of (leff)
3.45 BM.
The electronic spectra of Cu(II) complex show large band
at 17,993 cm1 which could also be cheap be assigned to
2B1g?
2A1g (c1) transition, consistent with a square planar
geometry around Cu(II) (Osman et al., 2004) which is further
veriﬁed with the aid of its magnetic of moment value (leff)
1.92 BM. The ligand ﬁeld parameters like crystal ﬁeld stabiliz-
ing energy (Dq), Racah parameter (B), Nephelauxetic ratio (b)
and b% have been calculated for Co(II), Ni(II), Cu(II) com-
plex and observed data are shown in Table 2.
3.3. IR and 1H NMR spectroscopic studies
The prominent bands observed in IR spectra of Schiff base
(HL) and its complexes are represented in Table 3. The IR
spectrum of free ligands shows a strong band at 1590 cm1
assigned to m(N‚CH) indicating the formation desired shift
base ligand. This used to be further proven by the presence
of a new band observed in 483–515 cm1 region assigned to
m(MAN), which is coordination of metal to azomethine nitro-
gen. The Schiff base (HL) (Fig. 1) a band at 2760 cm1 is
assigned to m(SH) vibration (Singh et al., 2006a,b). This band
disappeared in the spectra of the metal complexes indicating
deprotonation and complexation via sulfur. In the spectra of
Schiff base a band due to tautomeric form of C‚S is appeared
at 1114 cm1, in metal complexes this peak was disappeared.
Co(II), Ni(II) and Cu(II) complexes (Fig. 2a–c) show band at
350–379 cm1 have been assigned to m(MAS) (Liver, 1968).
Within the spectra of all complexes, bands appeared at 718–
785 cm1 and 350–379 cm1 were assigned to m(CAS) and m
(MAS), respectively (Osman et al., 2004; Singh et al., 2006a,b).
In the spectra of Co(II) and Ni(II) complexes, a broad band in
the region 3206–3395 cm1 indicated the presence of coordinated
water molecules. The presence of water molecule was also con-
ﬁrmed by thermal analysis.
The 1H NMR spectrum of Schiff base was recorded in
DMSO, using Tetramethylsilane (TMS) as an internal stan-
dard. The 1H NMR spectrum of ligand shows characteristic
azomethine proton singlet at d 11.07 ppm. The signal at d
13.27 ppm is ascribed to SH proton. The aromatic proton of
Schiff base appeared as multiplate at d 7.27–7.99 ppm and sin-
glet at d 2.28 ppm is due to methyl group. Since Co(II), Ni(II)
and Cu(II) complexes are paramagnetic, their 1H spectra could
not be obtained (Canpolat and Kaya, 2005). 1H NMR spec-
trum of Schiff base(HL) is indicated in Fig. 3.
3.4. Thermal analysis
Thermal decomposition of Co(II), Ni(II) and Cu(II) complexes
has been studied as a function of temperature by means of
TGA-DTA method. The decomposition temperatures, para-
lyzed products, percentage mass losses of the complexes and
270 S.A. Deodware et al.ash percentage are listed in Table 4. The Co(II) and Ni(II)
complexes exhibit three steps of decomposition. In ﬁrst step,
decomposition takes place from 50 to 180 C due to total
cleavage of the base metal complex along with hydroxide to
oxide transformation followed by concomitant release of water
molecules corresponding to loss of coordinated water mole-
cules. The second decomposition takes place from 175 to
425 C attributed to the release of organic moiety. Third
decomposition around 400–550 C can be attributed to the
release of triazole moiety. The decomposition of both the com-
plexes ended with oxide formation above 550 C. For Cu(II)
complex, ﬁrst step of decomposition at 50–425 C corresponds
to loss of organic moiety while second step corresponds to
removal of triazole molecules at 425–750 C. After 750 C
metal oxide is formed as a residue. Thermal curve analysis of
Co(II) complex is shown in Fig. 4.
3.5. Mass spectroscopic studies
The mass spectrum of ligand reveals parent peak due to molec-
ular ion (M+). The proposed molecular formulation of thisFigure 8 (a): Hydrogen bond interactions and charge interactions o
HL-Co.compound used to be proven through comparing their molec-
ular formula weight with m/z value. The molecular ion peak
used to be acquired at m/z 264. This worth is in excellent agree-
ment with the proposed molecular components of compound.
A mass spectrum of Schiff base (HL) is exhibited in Fig. 5.
3.6. X-ray diffraction analysis
The X-ray diffraction measurements were obtained using a X-
ray diffractometer (Rigaku Ultima IV, Japan made). The Cu
Ka radiation tube with line focus was operated at 40 kV and
40 mA. The X-ray powder diffraction patterns were obtained
in the range of 20–80 in steps of 0.0990. X-ray powder diffrac-
tion analysis of the ligand and its metal complexes was carried
out to determine the type of crystal system, lattice parameters
and the cell volume. As shown in Fig. 6(a) and (b) the XRD
patterns indicate a crystalline nature for the ligand and Cu
(II) complex, while Ni(II) and Co(II) complexes have amor-
phous nature. Indexing of the diffraction patterns was per-
formed using High Score Plus software. For the ligand and
Cu(II) complex d values, FWHM and relative intensities aref HL; (b): hydrogen bond interactions and charge interactions of
Table 9 Binding energy and critical interaction of ligand and metal complexes.
Sr. no. Molecule code Binding energy kcal/mol Interaction with amino acid
H-Bond Charge Hydrophobic
1 HL 40.53 GLN22 – LYS41 VAL26
2 HL-Co 48.98 –
3 HL-Ni 84.54 ASN142 GLU99, ASP97 GLY21, GLU99
4 HL-Cu 69.36 ASN142 – LYS41 ALA39
Figure 9 Correlation of binding energy and GI50 of HL and its
complexes.
High acting anti breast cancer agents 271given in Tables 5 and 6. From the indexed data the unit cell
parameters, volume, space group and average crystallite size
were also calculated and are listed in Table 7. The powder
XRD patterns of the Cu(II) complex are completely different
from those of ligand. XRD studies reveal that ligand has an
orthorhombic structure, while Cu(II) complex has tetragonal
structure. The full width at the half-maximum (FWHM) of
the diffraction peaks obtained from the reﬁnement was used
to calculate the particle size. The X-ray diffraction data were
determined by using Cu Ka radiation (k= 1.54060 A˚). The
average size of the samples was calculated with the help of
the Debye-Scherrer equation,
D ¼ ð0:90kÞ=ðbCoshÞ
where k is the wavelength (Cu Ka), b is the full width at the
half maximum (FWHM) and h is the diffraction angle. The
diffraction peaks indicate that the synthesized materials are
in the nanometer range.
3.7. Biological activity studies
All the newly synthesized compounds were screened for their
anticancer activity using SRB assay on theMCF 7 breast cancer
cell line. In the current protocol each cell line is inoculated on a
pre-incubated microtiter plate. The test agents are added at a
single concentration and the culture is incubated for 48 h. End
point determinations are made with Sulforhodamine B, a pro-
tein binding dye. The results for each test agents are reported
as the percentage growth of the tested cells. The compounds that
reduce the growth of any one of the cell lines to 32%or less (neg-
ative numbers indicates cell kill) are passed on for evolution
over a 5-log dose range. In the present screening program all
the compounds possessed growth to less than 32% are regarded
as active compounds (Holla et al., 2003, 2006). Adriamycin was
served as positive control compound in the cytotoxic assay. The
observed results are listed in Table 8.
3.8. Structure activity relationship (SAR studies)
In Fig. 7 of Co(II), Ni(II) and Cu(II) complexes are found to
be active against MCF 7 cell line up to molar dose of 104 M
which indicates their anticancer potential. SAR analysis of the
synthesized complexes indicated following points,
 1,2,4-Triazole shows moderate activity against MCF 7 cell
line. HL shows GI50 value, 64.1 which indicates the substi-
tution of the good electron withdrawing group ANO2 sufﬁ-
ciently affecting the polarity of the molecules.
 Cobalt metal complex showing profound activity than the
corresponding nickel and copper complexes. Chemical
properties of copper make it to take part in number ofbiological process such as electron transfer and catalysis.
Cobalt complex has ability to kill cancer cells are correlated
with the induction of the oxidative stress. Cobalt is an
important trace elements for humans in the form of vitamin
B12 (Cobalamin), and this metal plays a vital role in Protein
synthesis.
3.9. Molecular docking studies
In order to understand the possible mode of action of the syn-
thesized metal complex the molecular docking analysis was
carried out using crystal structure of the Human CDK 7. Opti-
mized structure of the metal complexes was utilized for the grip
based docking simulation was protein structure is kept rigid
and ligand structure is kept ﬂexible. All the molecules were
docked into the similar binding site of CDK 7 with binding
energy ranging from 33.57 kcal/mol to 96.36 kcal/mol.
Nickel complex is most active molecule having binding score
of 84.54 kcal/mol having critical interaction with amino
acids such as ASN142 (Hydrogen Bond interaction), GLU99
and ASP97 (Charge Interaction) and hydrophobic interaction
with GLY21 and GLU99. Hydrogen Bond Interactions and
Charge Interactions of Schiff base (HL) and Co(II) Complex
272 S.A. Deodware et al.are shown in Fig. 8(a) and (b) respectively. Binding energy and
critical interaction of all the compounds are given in Table 9.
Correlation of binding energy and GI50 of derivatives of Schiff
base and metal complexes are shown in Fig. 9.
4. Conclusion
The synthesized Schiff base acts as bidentate ligands and is coordi-
nated with the metal ion via nitrogen and sulfur. The bonding of ligand
to metal ion is validated through elemental evaluation, spectral reviews
(electronic, IR, 1H NMR, mass), TGA and magnetic measurement.
The Co(II) and Ni(II) complexes exhibit octahedral and Cu(II) tricky
displays square planar geometry. The entire compounds show off anti-
cancer endeavor against MCF-7 cell line. Metal complexes are more
potent in comparison with free ligand. The Co(II) complex indicates
quality anticancer exercise.
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